ADJUVANT THERAPY
Clinical trials for ADJUVANT THERAPY explained in plain language.
Never miss a new study
Get alerted when new ADJUVANT THERAPY trials appear
Sign up with your email to follow new studies for ADJUVANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop aggressive nose cancer from coming back
Disease control Not yet recruitingThis phase 2 trial tests whether the drug becotatug vedotin can prevent cancer from returning in 140 patients with high-risk nasopharyngeal carcinoma who have completed standard chemo-radiation. Participants are randomly assigned to receive the drug or standard care. The main goa…
Matched conditions: ADJUVANT THERAPY
Phase: PHASE2 • Sponsor: Kai Hu • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug cocktail aims to stop cervical cancer comeback after surgery
Disease control Not yet recruitingThis study tests whether a combination of two drugs (camrelizumab and famitinib) can help prevent cervical cancer from returning after surgery. It involves 30 women with specific cancer types and PD-L1 positive tumors. The main goal is to see how many patients remain cancer-free …
Matched conditions: ADJUVANT THERAPY
Phase: NA • Sponsor: Jin LI • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
AI may help decide who gets immunotherapy after liver cancer surgery
Disease control Not yet recruitingThis study will test whether a deep learning computer model can help doctors decide which liver cancer patients should receive immunotherapy (PD-1 inhibitors) after surgery to prevent the cancer from returning. About 300 patients who have had their liver cancer completely removed…
Matched conditions: ADJUVANT THERAPY
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC